Nalmefene Withdrawn Phase 4 Trials for Opioid Overdose Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05808881Clinical Outcomes From Nalmefene